| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2010 | CN101301291B Compound enrofloxacin injection for animals and preparation thereof |
| 09/01/2010 | CN101301274B Compound mequindox soluble powder for animals and preparation thereof |
| 09/01/2010 | CN101297860B Chinese medicinal composition for preventing and controlling heat stress and heatstroke of birds |
| 09/01/2010 | CN101297813B Compound niacin norfloxacin injection for animals and preparation thereof |
| 09/01/2010 | CN101292972B Use of 3,4-dihydroxy coffee acyl group tartaric acid in preparing medicaments for treating dementia diseases |
| 09/01/2010 | CN101273980B Preparation of Enrofloxacin microcapsule and method of preparing the same |
| 09/01/2010 | CN101264058B Huperzine A and its derivative or salts sustained-release nanometer granule and preparing method thereof |
| 09/01/2010 | CN101255422B siRNA sequence suppressing expression of bax gene |
| 09/01/2010 | CN101250182B 兰索拉唑钠 Lansoprazole sodium azole |
| 09/01/2010 | CN101250132B Polyfluoro ortho-hydroxybenzamide derivatives and uses thereof |
| 09/01/2010 | CN101244150B Medicament for treating enteritis |
| 09/01/2010 | CN101234160B Fat-reducing and liver-protecting Chinese medicine preparation and preparation thereof |
| 09/01/2010 | CN101229372B Medicine compounds for treating hypertension |
| 09/01/2010 | CN101229233B Chinese traditional medicine preparation for antiatheroscloresis and liver-protection, and preparingng method thereof |
| 09/01/2010 | CN101229147B Use of N-4-hydroxyphenyl retinamide on preparing anti-hepatic fibrosis medicine |
| 09/01/2010 | CN101220006B Buflomedil production method |
| 09/01/2010 | CN101209349B Application of carbon nano-tube as carrier in transferring anti-cancer medicine |
| 09/01/2010 | CN101209332B Medicinal composition for treating ovary inflammation caused by tubercle bacillus affection |
| 09/01/2010 | CN101209266B Compound sobering-up agent |
| 09/01/2010 | CN101204385B Child soluble amantadine hydrochloride soluble tablet |
| 09/01/2010 | CN101204378B Memantine hydrochloride oral medicine compound and its preparation method |
| 09/01/2010 | CN101190177B Dectancyl partial film forming gel composition and uses thereof |
| 09/01/2010 | CN101172102B Water-solubility cozymase Q10 supermolecule composition and method for preparing the same |
| 09/01/2010 | CN101147726B Good stability chloromycetin eyedrop and preparation method thereof |
| 09/01/2010 | CN101116668B Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients proteurs de cancers multiples |
| 09/01/2010 | CN101099846B Detumescence pain-relieving Babu plaster and preparing method |
| 09/01/2010 | CN101074229B 7-azaindirubin and 7-azaisoindigo derivative production and pharmaceutical use |
| 09/01/2010 | CN101062065B Sore carbuncle plaster |
| 09/01/2010 | CN101048399B 4-hetero aryl methyl substituted phthalazinone derivatives |
| 09/01/2010 | CN101028041B Slow-settling swelling ranular complex feed for large-yellow croaker scrod |
| 09/01/2010 | CN101014326B Medical emulsion of perfluororganic compounds and method for the production thereof |
| 09/01/2010 | CN101007794B N,N'-disubstituted piperazine derivative, and its preparation method and medicinal composition and uses |
| 08/31/2010 | USRE41614 Synthetic analogs of ecteinascidin-743 |
| 08/31/2010 | US7786328 e.g. benzoic acid 2-[4-dimethylamino-4-(3-methyl-benzyl)-cyclohexylcarbamoyl]-benzyl ester; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases |
| 08/31/2010 | US7786316 Metalloprotein inhibitors |
| 08/31/2010 | US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/31/2010 | US7786308 ethyl 3-(4-((4-fluorophenyl)(methoxycarbonyl)amino)piperidin-1-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate; COPD, asthma, urinary incontinence, glaucoma, Alzheimer's disease; side effects reduction; selectivity for subtypes M1-M5 recptors |
| 08/31/2010 | US7786307 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders |
| 08/31/2010 | US7786302 Producing valacyclovir hydrochloride in crystal form VIII by dissolving in dimethyl formamide at a temperature of 20-25 degrees C.; cooling the solution to 0-5 degrees C. and precipitating adding ethyl acetate, isolating, and, optionally, drying the hydrochloride VIII; solubility; bioavailability |
| 08/31/2010 | US7786292 compounds having a chelating moiety and an oligonucleotide sequence which includes one or more modified nucleobases such as hydroxynucleobases; inhibiting translation of a nucleic acid in an organism |
| 08/31/2010 | US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 08/31/2010 | US7786279 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 08/31/2010 | US7786221 drug polymer conjugates comprising biomaterials such as proteins linked through an activated moiety to a water soluble polyoxyethylene glycol derivatives |
| 08/31/2010 | US7786177 Phenylalanine enamide derivatives |
| 08/31/2010 | US7786176 rapidly forms a gel when in contact with sodium or calcium cations in the body for prolonged release of a therapeutic agent; low acyl gellan gum and a phenolic acid; no leakage; antibiotics, fungicides |
| 08/31/2010 | US7786175 Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation |
| 08/31/2010 | US7786174 Administering a compound that inhibits islet amyloid polypeptide-associated amyloid deposition, e.g., 8-hydroxy-5-quinolinesulfonic acid, sodium cyclohexylsulfamate, or octahydroisoquinolinyl-N-propanesulfonic acid; antidiabetic agents |
| 08/31/2010 | US7786173 for the treatment of autoimmune diseases such as uveitis, diabetes, rheumatoid arthritis, inflammatory bowel diseases or multiple sclerosis, and for prolonging allograft survival |
| 08/31/2010 | US7786172 percutaneously; cyclical mastalgia; may be formulated in a hydroalcoholic gel or an alcoholic solution |
| 08/31/2010 | US7786171 Amide derivatives as positive allosteric modulators and methods of use thereof |
| 08/31/2010 | US7786170 synergistic; Tumor necrosis factor related apoptosis inducing ligand and LAQ824 (N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide) Dacinostat, which augments Apo-2L/TRAIL-induced DISC (death inducing signaling complex) and apoptosis of human acute leukemia cells |
| 08/31/2010 | US7786169 several receptor sites can be blocked; inhibitors of leukotrienes, thromboxane A-2, cAMP PDE, eosinophil migration and lymphocyte migration; administering 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid (Tipelukast) |
| 08/31/2010 | US7786168 Phenolic acid salts of gabapentin in solid dosage forms and methods of use |
| 08/31/2010 | US7786167 Compositions containing prodrugs of florfenicol and methods of use |
| 08/31/2010 | US7786166 Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent |
| 08/31/2010 | US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 08/31/2010 | US7786164 Lipophilic di(anticancer drug) compounds, compositions, and related methods |
| 08/31/2010 | US7786163 such as 6-Amino-5-oxo-hexahydro-pyrrolo[2,1-b]thiazole-3-carbonitrile hydrochloride, useful as Dipeptidyl peptidase-IV inhibitors, for the treatment of diabetes, hyperglycemia, Syndrome X, obesity, atherosclerosis, inflammatory bowel disease and as immunology modulators |
| 08/31/2010 | US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof |
| 08/31/2010 | US7786161 prostaglandin receptor antagonists such as 2-(2-((4-methyl-2-(naphthalen-1-yl)pentanoyl)amino)-4-(pyrazol-1-ylmethyl) benzyl)benzoic acid, used for the prevention and/or treatment of diseases induced pain, skin disorders, allergies, urogenital disorders, Alzheimer's disease, cancer and dysmenorrhea |
| 08/31/2010 | US7786160 Combination of selected analgesics and COX-II inhibitors |
| 08/31/2010 | US7786159 Thrombopoietin mimetics |
| 08/31/2010 | US7786158 Compounds as opioid receptor modulators |
| 08/31/2010 | US7786156 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole) |
| 08/31/2010 | US7786155 such as N-(1,2-Dimethyl-propyl)-4-[2-(2-methyl-5-oxo-4,4-diphenyl-4,5-dihydro-imidazol-1-yl)-acetyl]-benzamide, used as neuropeptide Y receptor antagonists, useful in treating nervous system disorders, sleep disorders, cardiovascular disorders; metabolic disorders, inovulation and infertility |
| 08/31/2010 | US7786154 Substituted gamma lactams as therapeutic agents |
| 08/31/2010 | US7786153 Compounds that are useful for improving pharmacokinetics |
| 08/31/2010 | US7786152 Inhibiting 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD); use of sulfonamide-substituted N-heterocyclics including pyrroles, oxazoles, thiazoles, imidazoles and their fused analogs to treat diabetes, obesity, hypertension, arthritis, asthma, osteoporosis, breast cancer |
| 08/31/2010 | US7786151 Inhibiting SF2/ASF-dependent splicing of beta-globin pre-mRNA in vitro by suppression of Clk-mediated phosphorylation of SR proteins (serine/arginine-rich); a benzothiazole, TG003, is inhibitor of Clk/Sty(CDC2-like kinases); anticancer, antitumor; neurodegenerative diseases |
| 08/31/2010 | US7786150 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension |
| 08/31/2010 | US7786148 N-{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-trifluoromethylbenzamide; succinate dehydrogenase inhibitor or mitochondrial ubiquinol:ferricytochrome-c oxidoreductase inhibitor |
| 08/31/2010 | US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease |
| 08/31/2010 | US7786146 such as N-[1-(4-Trifluoromethylbenzyl)-4,6-dimethylindoline-5-yl]-3,3-dimethyl-butyramide, used as antiepileptic agents |
| 08/31/2010 | US7786145 Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors |
| 08/31/2010 | US7786144 Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists |
| 08/31/2010 | US7786143 Thiazolyl piperidine derivatives |
| 08/31/2010 | US7786142 1-(9H-carbazol-4-yloxy)propan-2-ol derivatives such as 1-(9H-carbazol-4-yloxy)-3-[(2,4-dimethoxybenzyl)-amino]propan-2-ol, used as phosphorylated signal transducers and activators of transcription (pSTAT3) and B-cell difeerentiation factor antagonists, for treating inflammatory diseases and cancer |
| 08/31/2010 | US7786141 Treating neurodegenerative diseases, psychological disorders, pain, glaucoma, dru eye, dry mouth, Sjogren's syndrome, asthma, bradycardia, wound healing, gastrointestinal disorders; amide- or urea-functional C5.C5N.C6 SPIRO(INDENE-2,4'-PIPERIDINE) RING structures; selective as to subtypes M1-M5 |
| 08/31/2010 | US7786140 Piperidine derivative having NMDA receptor antagonistic activity |
| 08/31/2010 | US7786139 phosphodiesterase inhibitors such as (E)-N'-(3,4-dimethoxybenzylidene)-2-(2-methylquinolin-4-ylthio)acetohydrazide, used for the treatment of psychological disorders, nervous system disorders, sleep disorders and as analgesic or anxiolytic agents |
| 08/31/2010 | US7786138 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
| 08/31/2010 | US7786137 sodium and calcium channel antagonists, such as 1-(2,4-Dichloro-benzoyl)-2,3-dihydro-1H-indole-5-sulfonic acid thiazol-2-ylamide, useful for treating neuropathic or inflammatory pain, arthritis, headaches, , epilepsy, neurodegenerative diseases, arrhythmia, psychological and nervous system disorders |
| 08/31/2010 | US7786136 Indazole-carboxamide compounds |
| 08/31/2010 | US7786135 Substituted pyrroline kinase inhibitors |
| 08/31/2010 | US7786134 camptothecin derivatives such as 10-(benzyl succinate)-7-ethylcamptothecin in the form of an emulsion or micelle, used for treating lung, mammary gland, colon or ovarian cancer |
| 08/31/2010 | US7786133 Chemically modified small molecules |
| 08/31/2010 | US7786132 1-(2-{4-[5-(2-Azetidin-1-yl-ethoxy)-benzo[b]thiophen-2-y1]-5-bromo-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine-2,4-dione, useful for treating diseases mediated by polo-like kinase, selected from rheumatoid arthritis and breast cancer, in a mammals; antiproliferative agents |
| 08/31/2010 | US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 08/31/2010 | US7786130 Pyridones useful as inhibitors of kinases |
| 08/31/2010 | US7786129 Piperazine derivatives of dialkyl oxindoles |
| 08/31/2010 | US7786128 6-[4-(butane-1-sulfonyl)-piperazin-1-yl]-2-phenoxymethyl-1-(4-trifluoromethoxy-benzyl)-1H-benzoimidazole; cannabinoid receptors antagonists/inverse agonists; neuroleptic, antidepressant, anxiolytic agent, cognition activator, drug addiction |
| 08/31/2010 | US7786127 Antineoplastic agents; polo like kinase effectors; such as 3-{[1-(2-chlorophenyl)ethyl]oxy}-5-[6-(1-piperizinemethyl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide |
| 08/31/2010 | US7786126 Combination preparations comprising SLV308 and a dopamine agonist |
| 08/31/2010 | US7786125 Neuroprotective small organic molecules, compositions and uses of related thereto |
| 08/31/2010 | US7786124 chemokine receptor (CXCR3) antagonists, used for the prophylaxis of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, side effect reduction, cutaneous delayed-type hypersensitivity responses, vision defects, diabetes, meningitis and tumors |
| 08/31/2010 | US7786123 Indolylmaleimide derivatives |
| 08/31/2010 | US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example |
| 08/31/2010 | US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals |
| 08/31/2010 | US7786120 3-(4-(Piperidin-1-yl)styryl)-5-(2-(methylamino)pyrimidin-4-yl)pyridin-2(1H)-one; autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease |
| 08/31/2010 | US7786119 Drug conjugates of ion channel modulating compounds |